These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 29935990

  • 1. Comparison of Cardiac Magnetic Resonance Imaging and Echocardiography in Assessment of Left Ventricular Hypertrophy in Fabry Disease.
    Hazari H, Belenkie I, Kryski A, White JA, Oudit GY, Thompson R, Fung T, Dehar N, Khan A.
    Can J Cardiol; 2018 Aug; 34(8):1041-1047. PubMed ID: 29935990
    [Abstract] [Full Text] [Related]

  • 2. Quantification of left ventricular mass by echocardiography compared to cardiac magnet resonance imaging in hemodialysis patients.
    Grebe SJ, Malzahn U, Donhauser J, Liu D, Wanner C, Krane V, Hammer F.
    Cardiovasc Ultrasound; 2020 Sep 16; 18(1):39. PubMed ID: 32938484
    [Abstract] [Full Text] [Related]

  • 3. Left ventricular mass and systolic function in children with chronic kidney disease-comparing echocardiography with cardiac magnetic resonance imaging.
    Arnold R, Schwendinger D, Jung S, Pohl M, Jung B, Geiger J, Gimpel C.
    Pediatr Nephrol; 2016 Feb 16; 31(2):255-65. PubMed ID: 26342304
    [Abstract] [Full Text] [Related]

  • 4. Discrepancies in Left Ventricular Mass Calculation Based on Echocardiography and Cardiovascular Magnetic Resonance Measurements in Patients with Left Ventricular Hypertrophy.
    Seo HY, Lee SP, Park JB, Lee JM, Park EA, Chang SA, Kim HK, Park SJ, Lee W, Kim YJ, Lee SC, Park SW, Sohn DW, Choe YH.
    J Am Soc Echocardiogr; 2015 Oct 16; 28(10):1194-1203, e2. PubMed ID: 26194306
    [Abstract] [Full Text] [Related]

  • 5. Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment.
    Niemann M, Herrmann S, Hu K, Breunig F, Strotmann J, Beer M, Machann W, Voelker W, Ertl G, Wanner C, Weidemann F.
    JACC Cardiovasc Imaging; 2011 Jun 16; 4(6):592-601. PubMed ID: 21679893
    [Abstract] [Full Text] [Related]

  • 6. Comparative assessment of 2-dimensional echocardiography vs cardiac magnetic resonance imaging in measuring left ventricular mass in patients with and without end-stage renal disease.
    Jakubovic BD, Wald R, Goldstein MB, Leong-Poi H, Yuen DA, Perl J, Lima JA, Liu JJ, Kirpalani A, Dacouris N, Wald R, Connelly KA, Yan AT.
    Can J Cardiol; 2013 Mar 16; 29(3):384-90. PubMed ID: 23103220
    [Abstract] [Full Text] [Related]

  • 7. Left ventricular wall thickness in patients with hypertrophic cardiomyopathy: a comparison between cardiac magnetic resonance imaging and echocardiography.
    Corona-Villalobos CP, Sorensen LL, Pozios I, Chu L, Eng J, Abraham MR, Abraham TP, Kamel IR, Zimmerman SL.
    Int J Cardiovasc Imaging; 2016 Jun 16; 32(6):945-54. PubMed ID: 26896038
    [Abstract] [Full Text] [Related]

  • 8. Prognostic Implications of Left Ventricular Hypertrophy and Mechanical Function in Fabry Disease: A Longitudinal Cohort Study.
    Chang HC, Kuo L, Sung SH, Niu DM, Yu WC.
    J Am Soc Echocardiogr; 2024 Aug 16; 37(8):787-796. PubMed ID: 38704103
    [Abstract] [Full Text] [Related]

  • 9. Use of cardiac magnetic resonance imaging to evaluate cardiac structure, function and fibrosis in children with infantile Pompe disease on enzyme replacement therapy.
    Barker PC, Pasquali SK, Darty S, Ing RJ, Li JS, Kim RJ, DeArmey S, Kishnani PS, Campbell MJ.
    Mol Genet Metab; 2010 Dec 16; 101(4):332-7. PubMed ID: 20875764
    [Abstract] [Full Text] [Related]

  • 10. Fabry disease: development and progression of left ventricular hypertrophy despite long-term enzyme replacement therapy.
    Maurizi N, Nowak A, Gruner C, Namdar M, Schmied C, Porretta AP, Barbey G, Monzambani V, Monney P, Barbey F.
    Heart; 2024 Jul 10; 110(15):997-1004. PubMed ID: 38749654
    [Abstract] [Full Text] [Related]

  • 11. A disproportionate contribution of papillary muscles and trabeculations to total left ventricular mass makes choice of cardiovascular magnetic resonance analysis technique critical in Fabry disease.
    Kozor R, Callaghan F, Tchan M, Hamilton-Craig C, Figtree GA, Grieve SM.
    J Cardiovasc Magn Reson; 2015 Feb 21; 17(1):22. PubMed ID: 25890002
    [Abstract] [Full Text] [Related]

  • 12. Assessment of Left Ventricular Mass and Hypertrophy by Cardiovascular Magnetic Resonance Imaging in Pediatric Hypertension.
    Supe-Markovina K, Nielsen JC, Musani M, Panesar LE, Woroniecki RP.
    J Clin Hypertens (Greenwich); 2016 Oct 21; 18(10):976-981. PubMed ID: 26988578
    [Abstract] [Full Text] [Related]

  • 13. Left ventricular structure and diastolic function by cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.
    Chacko BR, Karur GR, Connelly KA, Yan RT, Kirpalani A, Wald R, Jimenez-Juan L, Jacob JR, Deva DP, Yan AT.
    Indian Heart J; 2018 Oct 21; 70(1):75-81. PubMed ID: 29455792
    [Abstract] [Full Text] [Related]

  • 14. Aortic valve area, stroke volume, left ventricular hypertrophy, remodeling, and fibrosis in aortic stenosis assessed by cardiac magnetic resonance imaging: comparison between high and low gradient and normal and low flow aortic stenosis.
    Barone-Rochette G, Piérard S, Seldrum S, de Meester de Ravenstein C, Melchior J, Maes F, Pouleur AC, Vancraeynest D, Pasquet A, Vanoverschelde JL, Gerber BL.
    Circ Cardiovasc Imaging; 2013 Nov 21; 6(6):1009-17. PubMed ID: 24100045
    [Abstract] [Full Text] [Related]

  • 15. Left ventricular hypertrophy: do not forget Fabry disease. Diagnostic work-up and differential diagnosis.
    Paelinck BP, Bondue A, Robyns T, Eyskens F.
    Acta Cardiol; 2024 Aug 21; 79(6):642-649. PubMed ID: 38869089
    [Abstract] [Full Text] [Related]

  • 16. Global longitudinal strain, myocardial storage and hypertrophy in Fabry disease.
    Vijapurapu R, Nordin S, Baig S, Liu B, Rosmini S, Augusto J, Tchan M, Hughes DA, Geberhiwot T, Moon JC, Steeds RP, Kozor R.
    Heart; 2019 Mar 21; 105(6):470-476. PubMed ID: 30282640
    [Abstract] [Full Text] [Related]

  • 17. Synergistic prognostication of left ventricular hypertrophy and three-dimensional mechanical dyssynchrony in heart failure.
    Doi T, Nakata T, Yuda S, Hashimoto A.
    ESC Heart Fail; 2020 Feb 21; 7(1):361-370. PubMed ID: 31965750
    [Abstract] [Full Text] [Related]

  • 18. The Subclinical Cardiomyopathy of Friedreich's Ataxia in a Pediatric Population.
    Plehn JF, Hasbani K, Ernst I, Horton KD, Drinkard BE, Di Prospero NA.
    J Card Fail; 2018 Oct 21; 24(10):672-679. PubMed ID: 28986271
    [Abstract] [Full Text] [Related]

  • 19. Early detection of organ involvement in Fabry disease by biomarker assessment in conjunction with LGE cardiac MRI: results from the SOPHIA study.
    Weidemann F, Beer M, Kralewski M, Siwy J, Kampmann C.
    Mol Genet Metab; 2019 Feb 21; 126(2):169-182. PubMed ID: 30594474
    [Abstract] [Full Text] [Related]

  • 20. Left Ventricular Mass Quantification by Two-Dimensional Echocardiography in a Pediatric Population: Correlation with Cardiac Magnetic Resonance Imaging.
    Chu BJ, Lee T, Gilbreth JG, Nielsen JC, Ludomirsky A, Tretter JT, Bhatla P.
    Pediatr Cardiol; 2019 Feb 21; 40(2):412-420. PubMed ID: 30310940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.